(FY)Jun 30, 2023 | |
---|---|
Operating cash flow (direct method) | |
Cash income from operating activities | |
Cash paid | -922.87K |
Payments to suppliers for goods and services | ---772.27K |
Other cash payments from operating activities | ---150.6K |
Direct interest received | --62.17K |
Operating cash flow | ---860.7K |
Investing cash flow | |
Cash flow from continuing investing activities | -1.52M |
Capital expenditure reported | ---1.46M |
Net PPE purchase and sale | ---53.28K |
Cash from discontinued investing activities | |
Investing cash flow | ---1.52M |
Financing cash flow | |
Cash flow from continuing financing activities | 8.33M |
Net common stock issuance | --8.33M |
Cash from discontinued financing activities | |
Financing cash flow | --8.33M |
Net cash flow | |
Beginning cash position | --59.03K |
Current changes in cash | --5.95M |
Effect of exchange rate changes | --56.39K |
End cash Position | --6.07M |
Free cash from | ---2.38M |
Accounting Standards | US-GAAP |
No Data